Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Delivery Systems | 6 | 2023 | 2207 | 0.840 |
Why?
|
Microwaves | 1 | 2024 | 182 | 0.810 |
Why?
|
Lenses | 1 | 2022 | 40 | 0.800 |
Why?
|
Ablation Techniques | 1 | 2024 | 254 | 0.730 |
Why?
|
Lens, Crystalline | 1 | 2022 | 387 | 0.690 |
Why?
|
Microtechnology | 1 | 2019 | 64 | 0.640 |
Why?
|
Antineoplastic Agents | 10 | 2024 | 13648 | 0.630 |
Why?
|
Prostheses and Implants | 3 | 2021 | 1273 | 0.600 |
Why?
|
Neoplasms, Experimental | 3 | 2021 | 1229 | 0.570 |
Why?
|
Spectrum Analysis, Raman | 1 | 2018 | 252 | 0.530 |
Why?
|
Phantoms, Imaging | 2 | 2021 | 2475 | 0.460 |
Why?
|
Imaging, Three-Dimensional | 2 | 2024 | 4034 | 0.440 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1084 | 0.430 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2016 | 720 | 0.430 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 17075 | 0.390 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 993 | 0.380 |
Why?
|
Carcinoma | 1 | 2023 | 2312 | 0.370 |
Why?
|
Cerebellar Neoplasms | 1 | 2016 | 571 | 0.370 |
Why?
|
Medulloblastoma | 1 | 2016 | 658 | 0.360 |
Why?
|
Apoptosis | 5 | 2022 | 9514 | 0.350 |
Why?
|
Drug Monitoring | 1 | 2015 | 962 | 0.310 |
Why?
|
Melanoma | 2 | 2018 | 5719 | 0.310 |
Why?
|
Glioma | 1 | 2023 | 3493 | 0.300 |
Why?
|
Glioblastoma | 1 | 2023 | 3459 | 0.300 |
Why?
|
Mice, Nude | 4 | 2018 | 3618 | 0.280 |
Why?
|
Neoplasms | 7 | 2022 | 22340 | 0.280 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2054 | 0.260 |
Why?
|
Cytoskeleton | 1 | 2010 | 1178 | 0.240 |
Why?
|
Actins | 2 | 2016 | 2056 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 3 | 2018 | 5696 | 0.220 |
Why?
|
Animals | 20 | 2024 | 168764 | 0.220 |
Why?
|
Mice | 16 | 2024 | 81819 | 0.220 |
Why?
|
Endoscopy | 2 | 2024 | 1841 | 0.210 |
Why?
|
Neuropilin-1 | 1 | 2023 | 90 | 0.200 |
Why?
|
Pregnancy Outcome | 6 | 1993 | 2966 | 0.200 |
Why?
|
Doxorubicin | 3 | 2018 | 2230 | 0.190 |
Why?
|
Nitroquinolines | 1 | 2020 | 4 | 0.180 |
Why?
|
Galectin 3 | 1 | 2023 | 238 | 0.180 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3946 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5337 | 0.170 |
Why?
|
Enzyme Inhibitors | 3 | 2020 | 3715 | 0.170 |
Why?
|
Drug Synergism | 3 | 2020 | 1749 | 0.170 |
Why?
|
Chickens | 1 | 2021 | 842 | 0.160 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1132 | 0.160 |
Why?
|
Intercalating Agents | 1 | 2018 | 33 | 0.160 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2020 | 3608 | 0.160 |
Why?
|
Photons | 1 | 2022 | 572 | 0.150 |
Why?
|
Nucleotidyltransferases | 1 | 2020 | 242 | 0.150 |
Why?
|
Metal Nanoparticles | 1 | 2022 | 403 | 0.150 |
Why?
|
Growth Inhibitors | 1 | 2019 | 376 | 0.150 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 507 | 0.140 |
Why?
|
South Australia | 6 | 1993 | 27 | 0.140 |
Why?
|
Genes, erbB-2 | 1 | 2018 | 160 | 0.140 |
Why?
|
Temperature | 1 | 2024 | 2226 | 0.140 |
Why?
|
Obstetric Labor Complications | 4 | 1992 | 240 | 0.140 |
Why?
|
Pinocytosis | 1 | 2016 | 64 | 0.140 |
Why?
|
Workflow | 1 | 2021 | 862 | 0.130 |
Why?
|
bcl-X Protein | 1 | 2018 | 414 | 0.130 |
Why?
|
Receptors, Androgen | 1 | 2023 | 1088 | 0.130 |
Why?
|
Caspase 3 | 1 | 2018 | 731 | 0.130 |
Why?
|
Apgar Score | 3 | 1991 | 124 | 0.130 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2017 | 1758 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 134 | 0.120 |
Why?
|
Cerebral Palsy | 2 | 1990 | 481 | 0.120 |
Why?
|
Microfilament Proteins | 2 | 2016 | 1130 | 0.110 |
Why?
|
Swine | 1 | 2024 | 5988 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 647 | 0.110 |
Why?
|
Maternal Age | 3 | 1992 | 804 | 0.110 |
Why?
|
Serum Albumin | 1 | 2016 | 675 | 0.110 |
Why?
|
Pregnancy, High-Risk | 2 | 1991 | 121 | 0.110 |
Why?
|
Breech Presentation | 1 | 1993 | 38 | 0.100 |
Why?
|
Deoxycytidine | 1 | 2017 | 889 | 0.100 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 616 | 0.100 |
Why?
|
Breast Neoplasms | 3 | 2018 | 21056 | 0.100 |
Why?
|
Calibration | 1 | 2015 | 814 | 0.100 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2016 | 561 | 0.100 |
Why?
|
Humans | 35 | 2024 | 765968 | 0.100 |
Why?
|
Small-Area Analysis | 1 | 1992 | 51 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 852 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1410 | 0.090 |
Why?
|
Pregnancy Complications | 5 | 1992 | 2975 | 0.090 |
Why?
|
Rare Diseases | 1 | 2016 | 635 | 0.090 |
Why?
|
Amino Acids | 1 | 2016 | 1709 | 0.090 |
Why?
|
Antibodies | 1 | 2018 | 2417 | 0.090 |
Why?
|
Protein Kinases | 1 | 2017 | 1611 | 0.090 |
Why?
|
Benzodiazepines | 1 | 2016 | 1136 | 0.080 |
Why?
|
Microscopy, Atomic Force | 1 | 2010 | 250 | 0.080 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1188 | 0.080 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 5444 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 822 | 0.080 |
Why?
|
Cell Physiological Phenomena | 1 | 2010 | 148 | 0.080 |
Why?
|
Paclitaxel | 1 | 2016 | 1728 | 0.080 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11083 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4520 | 0.080 |
Why?
|
Elasticity | 1 | 2010 | 652 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7562 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2016 | 1727 | 0.070 |
Why?
|
Indoles | 1 | 2016 | 1839 | 0.070 |
Why?
|
Polymers | 1 | 2015 | 1621 | 0.070 |
Why?
|
Parity | 1 | 1991 | 931 | 0.070 |
Why?
|
Cell Movement | 2 | 2016 | 5194 | 0.070 |
Why?
|
Pyrimidines | 1 | 2019 | 3047 | 0.070 |
Why?
|
Gene Expression | 2 | 2016 | 7584 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2878 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1984 | 0.060 |
Why?
|
Stress, Mechanical | 1 | 2010 | 1668 | 0.060 |
Why?
|
Sarcoma | 1 | 2016 | 1802 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11022 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5389 | 0.060 |
Why?
|
Social Class | 1 | 1992 | 2007 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2627 | 0.050 |
Why?
|
Biopsy | 1 | 2015 | 6763 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10729 | 0.050 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2024 | 193 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11868 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4900 | 0.050 |
Why?
|
Orosomucoid | 1 | 2001 | 47 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4893 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18293 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2023 | 290 | 0.040 |
Why?
|
Cesarean Section | 1 | 1989 | 1431 | 0.040 |
Why?
|
Fibroblasts | 1 | 2010 | 4159 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36532 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12807 | 0.040 |
Why?
|
Female | 16 | 2019 | 396112 | 0.040 |
Why?
|
RNA Interference | 2 | 2019 | 2832 | 0.040 |
Why?
|
Signal Transduction | 3 | 2018 | 23601 | 0.040 |
Why?
|
Gold | 1 | 2022 | 482 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13451 | 0.040 |
Why?
|
Cell Cycle | 2 | 2016 | 2920 | 0.040 |
Why?
|
Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
Gammaproteobacteria | 1 | 2017 | 28 | 0.040 |
Why?
|
Australia | 3 | 1989 | 1258 | 0.040 |
Why?
|
Prognosis | 2 | 2016 | 29922 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1173 | 0.040 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2020 | 482 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 342 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2019 | 416 | 0.030 |
Why?
|
Pregnancy | 8 | 1993 | 30260 | 0.030 |
Why?
|
Receptor, erbB-3 | 1 | 2018 | 141 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5747 | 0.030 |
Why?
|
Chromatography, Gas | 1 | 2016 | 151 | 0.030 |
Why?
|
Infant Mortality | 2 | 1993 | 751 | 0.030 |
Why?
|
Nitrogen Isotopes | 1 | 2016 | 80 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1228 | 0.030 |
Why?
|
Prostatectomy | 1 | 2024 | 1782 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2016 | 205 | 0.030 |
Why?
|
Integrin alpha5beta1 | 1 | 2016 | 36 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 252 | 0.030 |
Why?
|
Tubulin | 1 | 2019 | 692 | 0.030 |
Why?
|
Ipecac | 1 | 1975 | 26 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65188 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9296 | 0.030 |
Why?
|
Androgens | 1 | 2023 | 1279 | 0.030 |
Why?
|
Accidents, Home | 1 | 1975 | 73 | 0.030 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2016 | 265 | 0.030 |
Why?
|
First Aid | 1 | 1975 | 71 | 0.030 |
Why?
|
Extracellular Space | 1 | 2016 | 563 | 0.030 |
Why?
|
Models, Statistical | 1 | 1989 | 5089 | 0.030 |
Why?
|
Hydrazines | 1 | 2016 | 223 | 0.030 |
Why?
|
Delivery, Obstetric | 2 | 1992 | 946 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2001 | 1015 | 0.030 |
Why?
|
Cisplatin | 1 | 2020 | 1658 | 0.030 |
Why?
|
Infant, Newborn | 5 | 1993 | 26346 | 0.030 |
Why?
|
Albumins | 1 | 2016 | 577 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2018 | 561 | 0.030 |
Why?
|
Hospitals, Special | 1 | 1974 | 88 | 0.030 |
Why?
|
Forecasting | 1 | 2023 | 2936 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1599 | 0.030 |
Why?
|
Poisoning | 1 | 1975 | 254 | 0.030 |
Why?
|
DNA Replication | 1 | 2020 | 1433 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2001 | 1930 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5302 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6113 | 0.030 |
Why?
|
Labor Onset | 1 | 1992 | 17 | 0.030 |
Why?
|
Quinolines | 1 | 2018 | 769 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2014 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 938 | 0.020 |
Why?
|
Fibronectins | 1 | 2016 | 719 | 0.020 |
Why?
|
Mice, SCID | 1 | 2017 | 2630 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2016 | 1718 | 0.020 |
Why?
|
Divorce | 1 | 1992 | 78 | 0.020 |
Why?
|
Quinazolines | 1 | 2018 | 1364 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 30198 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2048 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1751 | 0.020 |
Why?
|
Microtubules | 1 | 2016 | 1062 | 0.020 |
Why?
|
Nanoparticles | 1 | 2022 | 1964 | 0.020 |
Why?
|
Marital Status | 1 | 1992 | 426 | 0.020 |
Why?
|
Triazoles | 1 | 2016 | 897 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2457 | 0.020 |
Why?
|
Tumor Burden | 1 | 2016 | 1885 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 1992 | 493 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1490 | 0.020 |
Why?
|
Mental Disorders | 1 | 1989 | 6853 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 2394 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2423 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6220 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2034 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3430 | 0.020 |
Why?
|
Length of Stay | 2 | 1992 | 6485 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2822 | 0.020 |
Why?
|
Prenatal Care | 2 | 1992 | 1160 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1992 | 1158 | 0.020 |
Why?
|
Logistic Models | 2 | 1993 | 13266 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 1992 | 12056 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2618 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2018 | 2593 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3559 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7202 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4752 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5783 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2549 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2531 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6499 | 0.020 |
Why?
|
Random Allocation | 1 | 1989 | 2395 | 0.010 |
Why?
|
Male | 5 | 2024 | 363698 | 0.010 |
Why?
|
Bone Marrow Diseases | 1 | 1966 | 234 | 0.010 |
Why?
|
Urban Population | 1 | 1992 | 2040 | 0.010 |
Why?
|
Pyridines | 1 | 2016 | 2888 | 0.010 |
Why?
|
Intelligence | 1 | 1989 | 923 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 6203 | 0.010 |
Why?
|
Birth Weight | 1 | 1992 | 2121 | 0.010 |
Why?
|
Gestational Age | 1 | 1992 | 3609 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9525 | 0.010 |
Why?
|
Risk Factors | 4 | 1992 | 74840 | 0.010 |
Why?
|
Adult | 6 | 1993 | 223044 | 0.010 |
Why?
|
Proteins | 1 | 2016 | 5995 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8611 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8731 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10429 | 0.010 |
Why?
|
Spectrophotometry | 1 | 2001 | 288 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5929 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2001 | 1140 | 0.010 |
Why?
|
Odds Ratio | 1 | 1992 | 9649 | 0.010 |
Why?
|
Age Factors | 2 | 1992 | 18380 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2001 | 697 | 0.010 |
Why?
|
Pediatrics | 1 | 1974 | 3606 | 0.010 |
Why?
|
Sex Factors | 1 | 1993 | 10603 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13632 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 1992 | 7838 | 0.010 |
Why?
|
Liver Diseases | 1 | 1966 | 1303 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9373 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 1974 | 7875 | 0.010 |
Why?
|
Child, Preschool | 3 | 1989 | 42500 | 0.010 |
Why?
|
Drug Labeling | 1 | 1975 | 250 | 0.010 |
Why?
|
Infant | 2 | 1989 | 36386 | 0.010 |
Why?
|
Vomiting | 1 | 1975 | 647 | 0.010 |
Why?
|
Aged | 1 | 2024 | 171117 | 0.010 |
Why?
|
Family Practice | 1 | 1974 | 508 | 0.010 |
Why?
|
Drug Therapy | 1 | 1974 | 504 | 0.010 |
Why?
|
Organizations | 1 | 1951 | 172 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 223009 | 0.010 |
Why?
|
Retrospective Studies | 2 | 1989 | 81514 | 0.010 |
Why?
|
Morbidity | 1 | 1974 | 1749 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1989 | 39193 | 0.000 |
Why?
|
Niemann-Pick Diseases | 1 | 1966 | 27 | 0.000 |
Why?
|
Pigments, Biological | 1 | 1966 | 52 | 0.000 |
Why?
|
Histiocytes | 1 | 1966 | 95 | 0.000 |
Why?
|
Research Design | 1 | 2001 | 6209 | 0.000 |
Why?
|
Drug Prescriptions | 1 | 1974 | 1662 | 0.000 |
Why?
|
Residence Characteristics | 1 | 1974 | 2116 | 0.000 |
Why?
|
Time Factors | 2 | 1975 | 40065 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1974 | 3615 | 0.000 |
Why?
|
Child | 3 | 1975 | 80564 | 0.000 |
Why?
|
Diarrhea | 1 | 1966 | 1316 | 0.000 |
Why?
|
Respiratory Tract Infections | 1 | 1966 | 1008 | 0.000 |
Why?
|
Hospitalization | 1 | 1974 | 10808 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1966 | 12976 | 0.000 |
Why?
|
Adolescent | 1 | 1974 | 88835 | 0.000 |
Why?
|